Sean O’dOwd
Research Subjects
Research Interests
Sean O’dOwd has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Aisling Angela Jennings
Department of General Practice, School of Medicine, University College Cork, Cork, Ireland
1 shared publication - Alex J. McCarthy
Department of infectious disease, Imperial College London, London, UK
1 shared publication Antoinette O'COnnor
Dublin, Ireland)
1 shared publication- Antoinette O'COnnor
Tallaght Institute of Memory and Cognition, Tallaght University Hospital, Dublin, Ireland
1 shared publication - Aoife Fallon
Dublin, Ireland)
1 shared publication Aoife M Ni Chorcorain
Old Age Psychiatry Department, Carlow Kilkenny Mental Health Services , Kilkenny
1 shared publication
Latest Publications
- Open Access
- 1 February 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (2)
Co-designing a structured referral template to enhance dementia diagnosis: a modified e-Delphi study
Background: Dementia care is a health and social care priority, with rising prevalence driven by ageing populations worldwide. Timely and accurate diagnosis improves quality of life, enables access to support and is becoming even more critical due to the emergence of disease-modifying therapies for Alzheimer’s disease. Complex referral pathways can contribute to diagnostic delays and under-diagnosis. A structured, evidence-based referral template could enhance diagnostic efficiency and care quality. Methods: This study was conducted in two phases. First, a two-round e-Delphi survey was used to achieve consensus on items for inclusion in a dementia referral template. In the second phase, a modified Nominal Group Technique was employed with a multidisciplinary panel and Public and Patient Involvement (PPI) contributors to discuss, refine and prioritise items, ensuring clinical relevance and practical applicability. Results: The consensus process refined and prioritised 76 potential referral items into a final set of 11 essential components. The resulting concise template balances clinical relevance with usability, potentially supporting more efficient referral and triage. Items achieving the highest consensus included cognitive screening scores, rapid deterioration, problems with daily activities and patient safety concerns. Conclusion: The findings demonstrate the value of structured consensus methods in developing a practical, evidence-based referral template, tailored to optimise dementia diagnostic pathways. This is particularly important in the current evolving therapeutic landscape, to ensure that people with suspected dementia receive timely diagnosis and access to appropriate care and treatment options.
- 1 February 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (2)
Open AccessCo-designing a structured referral template to enhance dementia diagnosis: a modified e-Delphi study
Background: Dementia care is a health and social care priority, with rising prevalence driven by ageing populations worldwide. Timely and accurate diagnosis improves quality of life, enables access to support and is becoming even more critical due to the emergence of disease-modifying therapies for Alzheimer’s disease. Complex referral pathways can contribute to diagnostic delays and under-diagnosis. A structured, evidence-based referral template could enhance diagnostic efficiency and care quality. Methods: This study was conducted in two phases. First, a two-round e-Delphi survey was used to achieve consensus on items for inclusion in a dementia referral template. In the second phase, a modified Nominal Group Technique was employed with a multidisciplinary panel and Public and Patient Involvement (PPI) contributors to discuss, refine and prioritise items, ensuring clinical relevance and practical applicability. Results: The consensus process refined and prioritised 76 potential referral items into a final set of 11 essential components. The resulting concise template balances clinical relevance with usability, potentially supporting more efficient referral and triage. Items achieving the highest consensus included cognitive screening scores, rapid deterioration, problems with daily activities and patient safety concerns. Conclusion: The findings demonstrate the value of structured consensus methods in developing a practical, evidence-based referral template, tailored to optimise dementia diagnostic pathways. This is particularly important in the current evolving therapeutic landscape, to ensure that people with suspected dementia receive timely diagnosis and access to appropriate care and treatment options.
- 5 October 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (1) , 4-16
Dementia with Lewy bodies: a practical guide to clinical diagnosis and management
Dementia with Lewy bodies (DLB) is a leading cause of late-life dementia which remains underdiagnosed and misdiagnosed, and is associated with significant diagnostic delay compared with non-DLB dementias. There is a pressing need for timely and accurate diagnosis of neurodegenerative disease with the emergence of pathologically targeted disease-modifying therapies. This review aims to provide neurologists with practical advice on the recognition of classical, prodromal and variant forms of DLB. We discuss the appropriate use of diagnostic modalities, along with advice on focused and practical management in the clinical setting.
- 5 October 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (1) , 4-16
Dementia with Lewy bodies: a practical guide to clinical diagnosis and management
Dementia with Lewy bodies (DLB) is a leading cause of late-life dementia which remains underdiagnosed and misdiagnosed, and is associated with significant diagnostic delay compared with non-DLB dementias. There is a pressing need for timely and accurate diagnosis of neurodegenerative disease with the emergence of pathologically targeted disease-modifying therapies. This review aims to provide neurologists with practical advice on the recognition of classical, prodromal and variant forms of DLB. We discuss the appropriate use of diagnostic modalities, along with advice on focused and practical management in the clinical setting.
- 13 August 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (3) , e209343
Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
- 13 August 2024
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (3) , e209343
Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
- 7 December 2022
- Published by SAGE Publications in Advances in Communication and Swallowing
- Vol. 25 (2) , 109-113
Dysphagia in progressive supranuclear palsy: A scoping review protocol
BACKGROUND: One of the most prevalent types of atypical Parkinsonian syndrome is progressive supranuclear palsy (PSP). PSP is associated with early onset of dysphagia which can result in malnutrition, dehydration, and aspiration pneumonia, affecting quality of life and increasing mortality rate. To date, research describing dysphagia in PSP and its impact is scant. OBJECTIVE: The objective of this scoping review is to determine the characteristics of dysphagia in PSP, differences in dysphagia presentation according to PSP subtype, principal methods used for identifying and diagnosing dysphagia and the impact dysphagia has on quality of life in individuals with PSP. METHODS: The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews. The Preferred Reporting Items for Systematic Reviews and Meta Analysis extension for scoping reviews (PRISMA-ScR) will be used to guide the reporting of the review (Tricco et al., 2018). Articles completed at any time, which include participants with dysphagia and a clinical diagnosis of PSP will be included. Studies involving participants who have a co-morbidity/morbidities which could cause dysphagia and secondary research will be excluded. Relevant electronic databases, trial registries and grey literature without any date or language restrictions will be searched. Two independent reviewers will assess articles for eligibility and will extract relevant data. CONCLUSIONS: This scoping review will provide important evidence on dysphagia and PSP. It will describe the principal methods used for identifying and diagnosing dysphagia in this population. The results will guide future research in dysphagia and PSP.
- 7 December 2022
- Published by SAGE Publications in Advances in Communication and Swallowing
- Vol. 25 (2) , 109-113
Dysphagia in progressive supranuclear palsy: A scoping review protocol
BACKGROUND: One of the most prevalent types of atypical Parkinsonian syndrome is progressive supranuclear palsy (PSP). PSP is associated with early onset of dysphagia which can result in malnutrition, dehydration, and aspiration pneumonia, affecting quality of life and increasing mortality rate. To date, research describing dysphagia in PSP and its impact is scant. OBJECTIVE: The objective of this scoping review is to determine the characteristics of dysphagia in PSP, differences in dysphagia presentation according to PSP subtype, principal methods used for identifying and diagnosing dysphagia and the impact dysphagia has on quality of life in individuals with PSP. METHODS: The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews. The Preferred Reporting Items for Systematic Reviews and Meta Analysis extension for scoping reviews (PRISMA-ScR) will be used to guide the reporting of the review (Tricco et al., 2018). Articles completed at any time, which include participants with dysphagia and a clinical diagnosis of PSP will be included. Studies involving participants who have a co-morbidity/morbidities which could cause dysphagia and secondary research will be excluded. Relevant electronic databases, trial registries and grey literature without any date or language restrictions will be searched. Two independent reviewers will assess articles for eligibility and will extract relevant data. CONCLUSIONS: This scoping review will provide important evidence on dysphagia and PSP. It will describe the principal methods used for identifying and diagnosing dysphagia in this population. The results will guide future research in dysphagia and PSP.
- Open Access
- 16 April 2020
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (4) , 233-237
Assessment of the adequacy of counselling regarding reproductive-related issues in women of childbearing age on anti-epileptic drugs
Background: The use of anti-epileptic drugs (AEDs) in women of childbearing age (WCBA) necessitates careful counselling regarding reproductive-related issues. Aim: (i) To compare documentation of appropriate counselling regarding reproductive-related issues in WCBA prescribed AEDs for non-epilepsy vs. epilepsy indications, and (ii) to examine whether the frequency of counselling improved after introduction of ‘standardized typed advice’. Design: Retrospective audit and quality assessment and improvement programme. Methods: We analysed medical records of all WCBA prescribed gabapentin, pregabalin, topiramate, valproate or carbamazepine by a general neurology clinical service before (Study period A) and after (Study period B) introduction of standardized typed passages regarding potential teratogenicity ± interactions with hormonal contraception at a university teaching hospital. The χ2 test or the Fisher’s exact test was employed, as appropriate. Results: In WCBA prescribed AEDs for non-epilepsy indications, documentation of appropriate counselling regarding potential teratogenicity improved from 49% (17/35 patients) in Period A to 79% (27/34 patients) in Period B (P = 0.008). The frequency of counselling regarding teratogenicity was higher in patients prescribed AEDs for epilepsy compared with non-epilepsy indications in Study period A (100% vs. 49%, P = 0.002), but was no longer significantly different in Study period B (86% vs. 79%, P = 0.64). Documentation of counselling regarding potential interaction of enzyme-inducing AEDs with hormonal contraception did not significantly change between study periods. Conclusion: Significant improvements in documentation regarding potential teratogenicity of AEDs prescribed for non-epilepsy indications can be achieved by introducing standardized, typed passages copied to patients. Such a practice change is practical and widely applicable to neurological and non-neurological practice worldwide.
- 16 April 2020
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 114 (4) , 233-237
Open AccessAssessment of the adequacy of counselling regarding reproductive-related issues in women of childbearing age on anti-epileptic drugs
Background: The use of anti-epileptic drugs (AEDs) in women of childbearing age (WCBA) necessitates careful counselling regarding reproductive-related issues. Aim: (i) To compare documentation of appropriate counselling regarding reproductive-related issues in WCBA prescribed AEDs for non-epilepsy vs. epilepsy indications, and (ii) to examine whether the frequency of counselling improved after introduction of ‘standardized typed advice’. Design: Retrospective audit and quality assessment and improvement programme. Methods: We analysed medical records of all WCBA prescribed gabapentin, pregabalin, topiramate, valproate or carbamazepine by a general neurology clinical service before (Study period A) and after (Study period B) introduction of standardized typed passages regarding potential teratogenicity ± interactions with hormonal contraception at a university teaching hospital. The χ2 test or the Fisher’s exact test was employed, as appropriate. Results: In WCBA prescribed AEDs for non-epilepsy indications, documentation of appropriate counselling regarding potential teratogenicity improved from 49% (17/35 patients) in Period A to 79% (27/34 patients) in Period B (P = 0.008). The frequency of counselling regarding teratogenicity was higher in patients prescribed AEDs for epilepsy compared with non-epilepsy indications in Study period A (100% vs. 49%, P = 0.002), but was no longer significantly different in Study period B (86% vs. 79%, P = 0.64). Documentation of counselling regarding potential interaction of enzyme-inducing AEDs with hormonal contraception did not significantly change between study periods. Conclusion: Significant improvements in documentation regarding potential teratogenicity of AEDs prescribed for non-epilepsy indications can be achieved by introducing standardized, typed passages copied to patients. Such a practice change is practical and widely applicable to neurological and non-neurological practice worldwide.
- 10 February 2012
- Published by Wiley in Movement Disorders
- Vol. 27 (2) , 201
Does secretion of aberrant tau underlie lesion spread in tauopathies?
- 10 February 2012
- Published by Wiley in Movement Disorders
- Vol. 27 (2) , 201
Does secretion of aberrant tau underlie lesion spread in tauopathies?